Skip to main content
Yantoultra Ngui on Muck Rack

Yantoultra Ngui

Verified
Singapore
As seen in: Thomson Reuters, MSN, MSN Australia, MSN Ireland, MSN Money Canada, MSN Singapore, MSN UK, Bloomberg News, Business Insider, Daily Mail, ET Healthworld and
Southeast Asia Deals Correspondent with @Reuters. Formerly with Bloomberg @business, @WSJ, @theedgemalaysia. Truck Driver. Drummer. Taekwondo Black Belt Holder.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yantoultra

Contact Yantoultra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mylan to sell up to $363 million stake in India's Biocon, term sheet shows

|
By Yantoultra Ngui Verified
| MSN Verified
Yantoultra Ngui By Yantoultra Ngui SINGAPORE, July 13 (Reuters) - Mylan Inc, part of a global healthcare company Viatris, plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees ($363 million), according to a term sheet seen by Reuters. • The sale represents up to 5.64% of Biocon's outstanding shares. It is a secondary sale, meaning the shares are being sold by an existing investor and Biocon will not receive the proceeds.
Open in Who Shared View Duplicates (111) Issue with article?
See all 14,412 licensed articles (15,608 Total)